Personas / Equipo Humano

Lourdes Ibañez Toda

Buscador de publicaciones

Publicaciones

  • Fauser, BCJM, Chang, J, Azziz, R, Legro, R, Dewailly, D, Franks, S, Tarlatzis, BC, Fauser, B, Balen, A, Bouchard, P, Dahlgren, E, Devoto, L, Diamanti, E, Dunaif, A, Filicori, M, Homburg, R, Ibañez-Toda L, Laven, J, Magoffin, D, Nestler, J, Norman, RJ, Pasquali, R, Pugeat, M, Strauss, J, Tan, S, Taylor, A, Wild, R, Wild, S, Ehrmann, D, Lobo, R and Rotterdam ESHRE-ASRM-sponsored.

    Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)

    HUMAN REPRODUCTION . 19(1): 41-47. Nº de citas: 4790

    [doi:10.1093/humrep/deh098]

  • de Zegher F and Ibañez-Toda L.

    Novel insights into the endocrine-metabolic and reproductive consequences of prenatal growth restraint in girls. Girls-born-small become women-born-small.

    Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie . 66(5-6): 353-82. Nº de citas: 3

  • Ibañez-Toda L, Ferrer A, Ong K, Amin R, Dunger D and de Zegher F.

    Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome

    JOURNAL OF PEDIATRICS . 144(1): 23-29. Nº de citas: 109

    [doi:10.1016/j.jpeds.2003.08.015]

  • Ibañez-Toda L.

    Metmorfina e hiperandrogenismo ovárico

    Medicina Clinica Monografias . 5(1): 47-51.

  • Potau N, Williams R, Ong K, Sánchez-Ufarte C, de Zegher F, Ibañez-Toda L and Dunger D.

    Fasting insulin sensitivity and post-oral glucose hyperinsulinaemia related to cardiovascular risk factors in adolescents with precocious pubarche

    CLINICAL ENDOCRINOLOGY . 59(6): 756-762. Nº de citas: 19

    [doi:10.1046/j.1365-2265.2003.01919.x]

  • Ibañez-Toda L and De Zegher F.

    Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism:: Effects in adolescents and in women on third-generation oral contraception

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 88(10): 4720-4724. Nº de citas: 41

    [doi:10.1210/jc.2003-030117]

  • Ibañez-Toda L, Potau N, Enriquez G, Marcos MV and de Zegher F.

    Hypergonadotrophinaemia with reduced uterine and ovarian size in women born small-for-gestational-age

    HUMAN REPRODUCTION . 18(8): 1565-1569. Nº de citas: 95

    [doi:10.1093/humrep/deg351]

  • Ibañez-Toda L, Ong KK, Mongan N, Jääskeläinen J, Marcos MV, Hughes IA, De Zegher F and Dunger DB.

    Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 88(7): 3333-3338. Nº de citas: 127

    [doi:10.1210/jc.2002-021791]

  • Ibañez-Toda L, Ong K, Ferrer A, Amin R, Dunger D and de Zegher F.

    Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 88(6): 2600-2606. Nº de citas: 76

    [doi:10.1210/jc.2002-022002]

  • Ibañez-Toda L, Ong K, de Zegher F, Marcos MV, del Rio L and Dunger DB.

    Fat distribution in non-obese girls with and without precocious pubarche:: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche

    CLINICAL ENDOCRINOLOGY . 58(3): 372-379. Nº de citas: 115

    [doi:10.1046/j.1365-2265.2003.01728.x]